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ABSTRACT 
Systems immunology is a scientific field combining high-throughput analytic technologies 
and integrative data analysis to study the immune system from a holistic perspective. As the 
immune system is a complex integrated network of cells and proteins interacting in order to 
produce higher-level emergent behavior, the more traditional approach to immunological 
research is not fully capable of adequately describing these interactions. Systems 
immunology presents an alternative methodology and has already lead to new insight into 
mechanisms of human immunity. 
In the past century, to a large extent due to the introduction of sanitation, antibiotics, and 
vaccination, there has been a drastic decrease in the prevalence and severity of infectious 
disease. In parallel, the western world has experienced a dramatic increase in the incidence of 
immune-related diseases such as diabetes, asthma, allergies, multiple sclerosis, rheumatoid 
arthritis, and inflammatory bowel disease. This is often attributed to changes in lifestyle and 
children exhibit increased susceptibility to immune modulation by environmental factors. 
Although many such factors have been identified in epidemiological studies, the 
immunological mechanisms affected by these environmental factors and how they mediate an 
increased susceptibility to disease remain to be explored. 
The purpose of this thesis is to use systems immunology to study the development of the 
human immune system during the first years of life and identify connections between 
environmental and lifestyle exposures and the resulting immune phenotype. We identified a 
stereotypic pattern of change in immune cell composition over time that was consistent over 
all studies. The immune phenotypes of preterm and term children were different at birth but 
converged later in life, partially driven by environmental factors. We observed that the 
antibody repertoire and neutralization efficiency was similar for preterm and term children. 
We identified many environmental modulators of immune phenotype including gut 
microbiota composition, maternal antibody concentration, vaccination, and prenatal 
antibiotics. 
We are still in the early days of systems immunology. These studies hopefully represent only 
the beginning of a more rigorous and extensive application of systems immunology to the 
development of the human immune system. While many improvements in the collection and 
analysis of data have to be made, the initial results are encouraging. Hopefully, continued 
work in this area will reveal further connections between the environment and the immune 
system, as well as how the resulting phenotype leads to immunologic disease. 
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1 INTRODUCTION 
1.1 SYSTEMS IMMUNOLOGY IN HUMANS 
1.1.1 The Reductionist View of Immunology 
It has been almost 140 years since the original postulation of the immune system as an active 
force of the body for defense against pathogens, and it has influenced the way immunity has 
been studied ever since1. During this time, other functions such as the clearance of cancer2, 
wound healing3, pain signaling4, and many more5 have been associated with the cells of the 
immune system. Despite these seemingly varying roles of the immune system, the common 
theme is the maintenance of homeostasis, and the requirement to balance between generating 
an appropriate response to some stimuli while remaining unresponsive to others. This is 
achieved through an intricate network of interactions between immune cells, tissue-resident 
cells, and soluble mediators. In the last century, great strides were made towards mapping the 
cellular and molecular underpinnings of the immune system and their relationships. The 
majority of these studies were conducted in mice and include the discoveries of the dendritic 
and NK-cell lineages6,7, the B- and T-cell receptors8,9, and the MHC-locus10. In addition to 
the discovery of these immune system components, models for how these components 
perform the functions of the immune system have been discovered and tested in mice, such as 
the rules of tolerance of tissue grafts11, the concepts of T helper cell subsets12, and somatic 
recombination13. Together, these discoveries have furthered our understanding of the basic 
mechanisms of immune function immensely.  
A large share of human diseases has been shown to have some connection to the immune 
system. Obvious examples include infections, immunodeficiency disorders, and autoimmune 
conditions. Many other diseases such as atherosclerosis, cancer, and diabetes type 2 are not 
exclusively immune-mediated but contain an immune component. As these links to the 
immune system are being uncovered, the potential to modulate immunity to combat these 
diseases was realized as well. Indeed, many such treatments are in clinical use today, 
including immunosuppressants, cytokine therapy, HSCT, CAR T-cells, and monoclonal 
antibodies.  
While the success of such treatments cannot be denied, it is important to remember that they 
often come with severe and sometimes unexpected side effects14–16. There are several 
explanations for why we are not yet able to fully apply the advances made in our 
understanding of basic immunology in clinical practice. Before human trials begin, all tests of 
the efficacy and safety of novel therapies are performed in animals and utilize animal models 
of complex human diseases. This potentially presents a problem. While basic immunological 
components such as antibodies and T-cells are largely evolutionary conserved between mice 
and humans, the phenotype of complex diseases and the system-wide behavior of the immune 
system might not be17–21. The genetically identical background of laboratory mice together 
with husbandry in specific pathogen-free facilities poorly replicates the human situation22,23.  
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Unexpected behavior and downright detrimental side effects in the translation of 
immunological treatment of complex diseases from animal models to humans illustrate these 
issues. The reasons listed above explain a part of this discrepancy, but another important 
cause might be the reductionistic research methodology often applied in these cases. Studying 
individual cell types or limited systems of interactions between them will not replicate the in 
vivo situation, and will not enable accurate predictions of the behavior of the full system. The 
most successful discoveries in immunology often concern individual components such as cell 
types or genes. More complicated theoretical concepts have arguably been less successful. 
For example, the current theory of peripheral tolerance is a patchwork of imperfect central 
tolerance, regulatory T-cells, anergy, self-markers on non-immune cells, etc. The 
reductionistic research methodology is not sufficient to explain concepts like tolerance which 
emerges out of complex interactions of many cell types. Any attempt of oversimplification is 
bound to lead to an incorrect description and prevent accurate modeling. After going through 
some of the progress in technology and data analysis that made it possible, the alternative 
systems view of the immune system will be presented below. 
1.1.2 Technological Developments Within the Field of Immunology  
One reason that studying the immune system in a reductionist fashion has been the norm is 
because the immunoassays that were in common use in the previous century are limited in 
their throughput and scalability, as well as in the amount of data generated from them. With 
the advent of so-called omics-technologies, there has been an exponential increase in the 
amount of biological information that can be collected in a single experiment. As many of 
these technologies have become cheaper and commercially available, the capacity to study 
the immune system at an unprecedented level now exists at many universities. Furthermore, 
the introduction of novel technologies has led to the development of more sophisticated 
methods of data analysis to immunology, as well as the invention of completely new analysis 
tools to facilitate interpretation of these new types of data. 
One of the most profoundly important developments in biomedical research since the turn of 
the millennium is the introduction of next-generation sequencing technologies. This 
groundbreaking achievement has led to an array of methods for the study of the immune 
system, including sequencing of the complete genome and transcriptome of human and 
bacterial cells24,25, genome-wide study of epigenetic modifications26, and DNA-protein 
interactions27. In recent years, transcriptome sequencing of single cells has dramatically 
increased the resolution at which we can study biological processes28. Within the field of 
immunology, next-generation sequencing has been applied to identify causative mutations in 
immunodeficient patients29, study gene regulatory circuits in immune cells30, identifying 
epigenetic regulators of gene expression31, studying immune cell type heterogeneity32, and 
identifying cell fate decisions during T-cell differentiation33,34. 
In addition to using next-generation sequencing technology to study the immune system 
directly, an application that has rapidly become more popular is the gene sequencing of the 
human microbiota. This is accomplished either with targeted sequencing of genes with high 
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variability between species, or shotgun sequencing of the complete microbial bulk DNA35,36. 
Next-generation sequencing has been used to study general properties of the microbiome37,38, 
as well as its interaction with the immune system39–41. 
While single cell transcriptome sequencing allows for the quantification of thousands of 
different transcripts in a single cell, throughput is still low, although it is increasing42. In 
contrast, single-cell protein detection using flow cytometry can profile over 200 000 cells/sec 
in some cases43. However, the number of simultaneously measurable parameters in the same 
cell is much lower than for single cell transcriptome sequencing. Thanks to the invention of 
new detection probes and flow cytometer hard- and software, this number has increased in 
the last 20 years. In 1997, 10 parameter flow cytometry was state-of-the-art44; 7 years later, it 
had almost doubled45. Although recent developments have pushed it even further46, the 
overlap of the emission spectra of the fluorophores used for detection provides an upper limit 
for the number of parameters that can be analyzed simultaneously. 
Making use of mass spectrometry- instead of fluorescence-based detection, mass cytometry 
was developed as an alternative to flow cytometry. In mass cytometry, antibodies coupled to 
unique isotopes of rare earth metals that are not naturally present in cells are used as detection 
probes. After staining, cells are introduced into an argon plasma, where its molecular 
constituents, including the reporter ions, are dissociated into an ion cloud. The ions are 
directed into a time-of-flight mass spectrometer where the abundance of each unique 
detection probe can be measured. In this way, over 40 parameters can currently be detected 
simultaneously at a single cell level, and the theoretical limit is over 100 parameters. Thanks 
to the sensitivity of mass spectrometry measurements, there is little or no spillover between 
channels47. In the last 5 years, the number of scientific applications has rapidly expanded and 
include studying cellular phenotyping48, cell signaling49, transcriptional kinetics50, and 
developmental trajectories51,52. 
Another field that has made great progress in recent years is the field of proteomics. Within 
immunology, one of the main applications for this has been the detection of extracellular 
immune-related proteins in body fluids such as blood, cerebrospinal fluid, and synovial fluid. 
Since the 1970s, the gold standard for such measurements has been the antibody-based 
enzyme-linked immunosorbent assay (ELISA)53. Although the ELISA is still frequently used 
to this day, it suffers from unspecific antibody binding and is hard to parallelize.  
To get around this problem, several technologies based on different methods of detection 
have been developed. These include planar antibody array technologies54, suspension bead 
arrays55, proximity extension-based methods56, and mass spectrometry-based detection 
methods57. Each of these methods has its own advantages and disadvantages in terms of 
throughput, specificity, sensitivity and pricing. Because of this, no technology has been 
universally adopted for the measurement of immune-related proteins in solution. 
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1.1.3 Developments in Data Analysis 
The exponential increase of the rate at which biological data can be generated has put 
increasing demands on storage, handling, and analysis of data. The raw output of the 
technologies described above often includes a lot of noise and technical artifacts and can be 
impossible to analyse directly. Often, careful preprocessing of the data has to be performed 
before any biological interpretation is made. Even then, many of the more traditional 
statistical methods might not always be suitable for such multidimensional data, which often 
require simplification by clustering or dimensionality reduction. Some types of biological 
questions might even require completely new types of mathematical models. 
Much of the technological developments in recent years concern measuring multiple 
parameters in single cells. Good examples of this are mass cytometry and single-cell 
transcriptome sequencing. Many tools to analyze such complex data sets have been 
developed. To answer the question of how many different cell types exist in a sample and 
what they look like, several unsupervised clustering algorithms have been applied to such 
data58–60. These approaches can be used to identify populations of cells that differ 
significantly in size between groups such as patients and healthy controls61.  
However, such analyses assume that cells cluster in discrete groups. For some biological 
processes such as cell differentiation, cells might instead be continuously distributed in 
parameter space. In these cases, using clustering-based methods will not accurately model the 
underlying biological process. Instead, it would be more correct to identify trajectories in the 
data, e.g. changes in parameter levels as a cell differentiates from a stem-cell phenotype to a 
mature phenotype. Tools to identify such trajectories have been developed and applied both 
to mass cytometry51,52, and single cell transcriptome data62,63. 
Another approach is to try to reduce the number of dimensions to facilitate visualization, 
while still trying to retain the relevant features of the full data set. Different types of 
dimensionality reduction algorithms capture different aspects of the data set, and the choice 
of algorithm is dependent on the structure of the data, as well as the biological question. 
Dimensionality reduction can be performed on single-cell level, for example using principal 
component analysis64, t-distributed stochastic neighbor embedding65,66, and diffusion maps67.  
1.1.4 The Holistic View of Immunology 
What all the novel technologies described above have in common is the potential for high 
sample throughput and analysis of multiple parameters simultaneously. For the first time, this 
has allowed systems-wide properties of the human immune system to be studied on a 
population level. In other words, instead of asking biological questions pertaining to a single 
cell type or a single protein, studying many cell populations and serum proteins 
simultaneously in large cohorts allows us to ask questions regarding the collective behavior 
and patterns of these immune components. In addition, by performing these measurements at 
multiple occasions over time, temporal aspects of the complexity of immune system behavior 
can be captured. Previously, research in humans was often avoided due to the large amounts 
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of interindividual differences in genetic makeup and environmental exposures, but the higher 
accuracy, throughput, and parameter numbers of new technologies and data analysis methods 
make it possible to utilize such variation to gain novel biological insight68. In addition, a 
renewed focus on human studies holds promise for discoveries that are more easily translated 
to the clinical setting20,21. 
Recently, these technologies have been used to ask questions about the immune system in a 
more integrated system-wide setting. One such question relates to variation in immune 
phenotype in healthy adults. A few studies have measured a large number of immune 
parameters and compared the variation between individuals with the variation within 
individuals over time. On a system-wide level, most measurable immune parameters show 
relatively large variation between adult individuals, while the variation within any individual 
remains relatively low69–71. Although such intra-individual stability can be perturbed by an 
immunological stimulus such as an infection or vaccination, individuals usually return to an 
immunological baseline72.  
Another field where recent technical developments have furthered immunological research is 
the study of the relative contribution of genetic and non-genetic factors to immune system 
phenotype and function.  In the last few years, several studies have addressed this question by 
measuring large numbers of immune parameters and in different ways estimated or predicted 
the degree of genetic and environmental influence on the immune system69,73–77. Results from 
these studies vary, partially due to differences in methodology, but it seems like both genetic 
and non-genetic factors are important although non-genetic factors have a slightly larger 
influence78. 
These are just a few examples of studies made available by the combination of recent 
technological advances together with more systems-based data analysis. Other uses include 
studying transcriptional control of the immune system79,80, vaccine responses81–83, and host-
pathogen interactions84. Considering the tremendous pace at which technological progress is 
being made, it seems likely that this trend towards more holistic analyses of the human 
immune system will continue. 
1.1.5 Conclusions 
Complex interactions between immune system components and the behavior that emerges 
from them require a new scientific paradigm to be properly understood. As new technologies 
have enabled measurements of complete genomes, transcriptomes, and proteomes, our focus 
must shift from trying to understand single molecular or cellular interactions to the emergent 
phenomena resulting from thousands of interactions over time. This requires the adoption of 
more complex mathematical models and analysis tools, and we might have to settle for 
merely being able to mathematically model an immunological system without having an 
intuitive understanding of it. However, the reward will be an improvement in our ability to 
predict and manipulate this system of interactions to elicit the desired response. In this way, 
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such a paradigm can lead to a completely novel way of developing drugs to treat immune-
related diseases. 
1.2 THE EARLY LIFE DEVELOPMENT OF THE HUMAN IMMUNE SYSTEM 
1.2.1 Introduction 
As discussed above, it has become increasingly clear that immune phenotypes in adult 
humans are heterogeneous, and that these phenotypes to a large extent are determined by 
non-genetic factors. However, which these factors are and when they exert this influence is 
less clear. There is ample evidence from the field of epidemiology that environmental 
influences early in life can predispose for a number of diseases, exemplified by the hygiene 
hypothesis85 and Barker’s hypothesis86. A deeper knowledge of these processes could lead to 
a better understanding of these conditions and how to prevent and treat them. 
1.2.2 Immune Cell Composition of Blood Throughout Development 
Immune cells appear as early as gestational week 4 in human development87. The earliest 
cells that appear belong to the monocyte lineage, followed by granulocytes and lymphocytes. 
Much of what is known about hematopoiesis throughout development comes from studies in 
mice88. Initially, hematopoiesis takes place in the yolk sac and other extra-embryonic tissues. 
These sites later colonize the fetal liver, which becomes the major site of hematopoiesis 
around gestational week 6. Late in the second trimester, production moves to the bone 
marrow, which is the major site of hematopoiesis at birth87.  
Whether the propensity of hematopoietic stem cells to differentiate into various immune cells 
differ between these anatomical sites or throughout development is not known. In 1989, 
Leonore and Leonard Herzenberg suggested that this might be the case, and this has become 
known as the layered immune system hypothesis89. There are clues, both in humans90 and 
mice91, that this might be the case, but the question is still not settled92,93. 
Naturally, it has been difficult to study the levels of white blood cell subsets in the human 
fetus, and much more is known about postnatal development. Although a number of studies 
have looked at counts and frequencies of white blood cells after birth, they’re difficult to 
compare due to variations in the cohort under study, the source of blood, gestational age at 
birth and age binning. However, there are a few apparent patterns, which together suggest a 
robust developmental process that takes place from birth up until adulthood. 
There is a constant decrease in the white blood cell count from birth all the way until 
adulthood where it stabilizes94,95. B-cell count and frequency increases up until around 1-2 
years of age, followed by a decrease to lower levels in adulthood94–98. The CD4:CD8 ratio 
decreases from birth to adulthood94–96,99–101, and there is a continuous decrease of the ratio 
between naïve and memory T-cells, both in the CD4+ and CD8+ T-cell lineages94,95,99,102. 
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1.2.3 Environmental Influence on the Developing Immune System 
As described above, non-genetic factors have been shown to have a large influence on the 
human immune system in adults69,73,103. Environmental factors in early life such as mode of 
delivery, diet, medication, and infections have been increasingly acknowledged as important 
shapers of the human immune phenotype104,105. There are even indications that some 
environmental exposures during the neonatal period are critical for normal immune system 
development106,107.  
There are many interesting examples of non-genetic factors having an influence on the 
immune phenotype of the neonate. For example, to be born with caesarian section has been 
associated with higher cord blood leukocyte counts and a higher granulocyte:lymphocyte 
ratio in babies, compared to vaginal delivery108–110. Vaginal delivery was also associated with 
higher levels of several cytokines such as IL-2, IL-6, IL-8, and IFN-y108,109,111, possibly 
related to the increase in stress hormone levels induced by labor112. Numerous other 
environmental factors have been connected to immune phenotype, including maternal 
smoking113, breastfeeding114–117, viral infections114, and antigen exposure118,119. 
Recently, it has become clear that a significant part of the non-genetic influence on the 
immune system is mediated through modulation of the gut microbiota120,121. The microbiota 
is established almost immediately after birth, through colonization by bacteria that the baby is 
exposed to during labor. It is not completely stabilized until several years after birth37. Like 
the immune system, gut microbiota composition is partially shaped by host genetics122–124. 
Also, there are large geographical variations in gut microbiota composition, something which 
could be due to both lifestyle and genetics37. However, some of the clearest associations are 
between gut microbiota composition and environmental factors. Specifically, perinatal factors 
such as diet125–129, antibiotics125–127,130, and mode of delivery126,127 have all been shown to 
influence microbiota composition. In addition, it is becoming increasingly clear that there is a 
connection between the microbiota, immune phenotype, and the development of immune-
related disease131,132. 
1.2.4 Summary 
While the introduction of antibiotics and childhood vaccination has been dramatically 
successful in reducing child mortality in the developed world, there has been a parallel 
increase in the rates of many immune-related diseases such as multiple sclerosis, type I 
diabetes and inflammatory bowel disease. It seems clear that some part of a modern lifestyle 
increases the risk of developing these diseases, but exactly what part and how is less obvious. 
Although the diseases listed above are manifested differently, the common factor is the 
generation of an inappropriate immune response.  
The immune system needs stimulation as part of its normal development. In addition, it needs 
exposure to “safe” antigens under appropriate conditions to develop tolerance. As is shown 
by the rapid increase in the incidence of autoimmune diseases in developed countries, some 
recent change in lifestyle is interfering with normal immune development. However, the fact 
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that this is manifested so differently in different people and seems to be influenced by 
genetics as well as your environment, hints at a complex cause133,134. These autoimmune 
diseases are often manifested as inflammation and dysfunction of both innate and adaptive 
immunity, together with a failure of tolerance to specific antigens. To understand such 
complex processes requires the integration of astute clinical observations and biological 
understanding with systems-wide immune system analysis and new mathematical models. 
Studying multifactorial disease under such a new paradigm could hopefully lead to a deeper 
appreciation of how to manipulate the immune system with the intention of preventing 
disease without interfering with its ability to perform its normal functions. 
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2 AIMS 
The overall aim of this thesis is to study the natural development of the human immune 
system at various time periods and conditions. We intentionally tried to identify and study 
cohorts of children growing up under diverse environmental circumstances where we had the 
opportunity to closely follow them and collect samples regularly. The intention was to use 
high-dimensional methodologies to study immunity on a system-wide level and, if possible, 
also collect longitudinal samples to study changes within the same individual. 
Paper I 
In this paper, we wanted to study the effect of preterm birth on the development of the human 
immune system during the first months of life135. We used mass cytometry, PEA, and 16S 
rRNA sequencing to follow changes in immune cell composition, plasma protein 
concentrations, and gut microbiota composition respectively. To begin with, we were 
interested in studying the natural development of these components. We compared term and 
preterm children in order to identify any differences due to their vastly different 
environmental exposures. We also collected blood samples from parents to see how each 
child developed in relation to genetically related individuals, but also to adults in general.   
Paper II 
This study was conducted in the same cohort as paper I, but here we wanted to study the 
levels of maternal antibodies in the term and preterm children136. We used the recently 
developed VirScan method to systematically survey the presence of maternal antibodies 
against all viruses known to infect humans. First, we identified which antiviral antibodies 
were present and whether there were any differences between the term and preterm children. 
Next, as VirScan identifies antibody specificity on an epitope level, we wanted to know 
whether the number of immunodominant epitopes differed between viruses. Finally, we 
identified maternal factors that influence the concentrations of antibodies against a few 
different viruses.  
Paper III 
In this study, we wanted to look at the longitudinal development of children growing up with 
an anthroposophic lifestyle. We measured immune cell composition and functionality using 
mass cytometry. First, we looked at general changes in composition and phenotype of white 
blood cells during the first 5 years of life in relation to samples taken from the mothers. We 
then looked at changes in the capacity for cytokine production in different immune cell 
subsets over time. Finally, we wanted to find environmental exposures related to the 
anthroposophic lifestyle that might explain these changes. 
Paper IV 
Here we wanted to study the impact of environmental factors on the immune cell composition 
in a large cohort of Norwegian and Swedish children followed from birth where large 
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amounts of metadata are collected through site visits and questionnaires. We wanted to use 
mass cytometry to study the natural variation of immune cell composition in these children 
and how they relate to adults. Most importantly, we wanted to determine how lifestyle and 
environmental factors influence the immune system of 1-year-olds. 
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3 METHODS 
3.1 STUDY DESIGN, TEST SUBJECTS, AND SAMPLES 
The data in this thesis is collected from three separate pediatric cohorts, all with their own 
advantages and drawbacks. They have several things in common. In all three studies, 
recruitment of families happened before or in conjunction with birth, they are all prospective 
cohort studies, and they all involve the collection of blood samples and metadata on 
environmental and lifestyle factors. However, there are also several differences in terms of 
the time periods under study, which experimental analyses were applied, and the specific 
environmental exposures involved. 
3.1.1 Paper I & II 
Paper I & II are based around the TELLUS cohort of newborn babies, organized from the 
Karolinska University Hospital, Huddinge. Sample collection began in 2014 and is still 
continuing at the time of writing. Families are recruited to the study during their hospital stay 
in relation to delivery. The cohort consists of term children (>= 37 weeks of gestational age at 
birth) as well as very preterm children (< 30 weeks of gestational age at birth). Blood and 
fecal samples, are collected at birth and approximately 1, 4, and 12 weeks after birth. Blood is 
also collected from both parents a few days after birth, and from the mother again 
approximately 12 weeks after birth. From the blood samples, whole blood was preserved for 
mass cytometry. Plasma was extracted after centrifugation for PEA and VirScan. PBMCs for 
transcriptomic analysis were extracted from the remaining pellet with density gradient 
centrifugation. DNA was extracted from the fecal samples using physical and chemical 
abrasion, followed by column purification. 
3.1.2 Paper III 
Paper III is a subproject of the prospective cohort group ALADDIN consisting of families 
enrolled between 2004 and 2007 at healthcare centers in the community of Järna, southwest 
of Stockholm. There were two study groups: one had a modern, western lifestyle, the other 
had an anthroposophic lifestyle, which involves among other things longer periods of 
breastfeeding, a more traditional diet, and a reluctance to take antibiotics and to vaccinate. 
Blood samples were collected from the mothers during pregnancy, and cord blood was 
collected from the children at birth, as well as peripheral blood at the ages of two and five. 
From all samples, PBMCs were collected with density gradient centrifugation and used for 
both phenotyping and functional assays with mass cytometry.   
3.1.3 Paper IV 
Subjects in paper IV are part of the larger PreventADALL study. PreventADALL is a 
prospective cohort study coordinated from Oslo, Norway, and has so far included more than 
2500 families. Mothers are recruited to the study in connection to their midwife visits during 
pregnancy. Families submit questionnaires regarding lifestyle and environmental factors 
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throughout the study period. Data is also collected from clinical databases and during regular 
site visits. For this study, a subgroup of 101 children was blood sampled at the age of 
approximately 12 months, and whole blood was stored for subsequent phenotyping using 
mass cytometry.  
3.2 EXPERIMENTAL METHODS 
3.2.1 Mass Cytometry 
Mass cytometry is an antibody-based technology for the high-throughput analysis of protein 
levels in single cells (Figure 1). It is analogous to flow cytometry in many ways but uses 
mass spectrometry as a detection method instead of fluorescence. Cells in suspension are 
stained with monoclonal antibodies conjugated to purified isotopes, primarily elements from 
the lanthanide series, that are used as detection probes. Cells are introduced into the machine 
one by one in water droplets, the water is evaporated, and the cells are guided into an argon 
plasma. The resulting ion cloud is passed through an electric field in order to filter away 
naturally abundant ions with low mass such as carbon and oxygen that would interfere with 
the signal, leaving only the purified isotopes that were used as detection probes. Ion 
abundance is determined with a time-of-flight mass spectrometer where ion abundance is 
directly related to the amount of bound antibody.  
 
Figure 1 An overview of mass cytometry. Reprinted with permission from Cell Press. 
 
 
The most common application for mass cytometry is cellular phenotyping which involves the 
detection of surface proteins whose presence or absence indicates the cellular lineage and/or 
functional status of each cell. Although the earliest and still most common application has 
been phenotyping of immune cells from peripheral blood49, the phenotyping of other tissues 
is possible as well137. More recently, there have also been several developments towards the 
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phenotyping of tissues138,139. Antibodies can also be used for the functional assessment of 
cells. Signaling through phosphorylation cascades can be investigated through intracellular 
staining of the phosphorylated epitopes of signaling proteins, and cytokine production can be 
evaluated by stimulating cells for a few hours while inhibiting protein secretion and then 
perform intracellular staining of the cytokines that accumulate in the cell. Other attributes 
such as the cell cycle stage, history of cell division, and cell size can be measured as well. 
While the primary application of mass cytometry is single-cell detection of proteins using 
antibodies, other types of detection probes are available as well such as DNA-staining 
compounds140, oligonucleotides50, and viability dyes141.  
3.2.2 Proximity Extension Assay 
PEA makes use of the proximity ligation assay for detection, which consists of an antibody 
pair specific against different epitopes of the same protein. Each antibody in the pair has an 
oligonucleotide tail attached to its Fc region. The oligonucleotides of the pair are 
complementary to each other and form a circular strand when both antibodies bind to the 
protein at the same time, which can be amplified with the rolling circle amplification reaction. 
With such amplification, even very low numbers of bound antibodies can be detected. 
The use of two different antibodies for the detection of a single protein significantly lowers 
the risk of false positives due to unspecific binding, as the generation of a signal requires that 
both antibodies bind in close proximity to each other. Also, many such reactions of different 
antibody pairs can be performed simultaneously in the same sample, enabling the detection of 
many different proteins, and the oligonucleotide sequence of each antibody pair serves as an 
identifier for that specific reaction. Finally, the amplified strands are detected with qPCR, 
providing another opportunity for signal amplification. A stronger signal will correlate with 
the concentration of the specific protein in the sample and can be compared between samples. 
3.2.3 mRNA Sequencing 
Out of the three parts of the central dogma of biology: DNA, mRNA, and protein, only 
mRNA and protein are indicative of the phenotype of cells, as well as their current functional 
state. While the information gained from measuring the levels of mRNA and protein in cells 
is comparable, they each have their advantages and disadvantages.  
Proteins are more abundant than their corresponding mRNA molecules, their expression 
levels represent the actual phenotype of the cells, and contain information about 
posttranslational modifications. However, comprehensive detection of all proteins in a 
population of cells is still not possible and is limited to detection of either a predefined set of 
proteins using antibodies or the detection of the most abundant proteins with technologies 
such as mass spectrometry. mRNA molecules are more fickle compared to their protein 
counterparts but have the major advantage that they can be detected with the technology of 
DNA sequencing, allowing the unbiased detection of all mRNA molecules of a population of 
cells, although there are lower limits of detection here as well.  
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For the detection of mRNA in a population of cells through sequencing, mRNA is extracted 
from the cells through lysis of the cellular membranes and stabilized. It is converted into 
DNA with the use of the enzyme reverse transcriptase and then amplified through PCR. The 
resulting DNA material can be sequenced using high-throughput short-read sequencing 
technology. Reads are mapped to a reference database of the human transcriptome, and after 
correction for transcript size, the number of reads from each gene will reflect the abundance 
of mRNA molecules at the time of sampling. 
3.2.4 16S rRNA Sequencing 
The 16S rRNA sequencing technology uses the fact that the gene for the 16S RNA subunit of 
the bacterial ribosome is present in all bacteria and is not evolutionarily conserved. Because 
of this, the genetic sequence of the 16S rRNA gene serves as a molecular identifier of a 
bacterial species.  
The first step of 16S rRNA sequencing of a bacterial sample is the extraction of DNA 
through mechanical and chemical abrasion. This is one source of bias in this method, as 
bacteria differ in their susceptibility to degradation. The DNA is purified using a spin 
column, and the genetic material is amplified with PCR and sequenced. To determine the 
bacterial origin of a specific sequence, each sequence is mapped to a reference library of 
known bacterial strains and the sequences of their 16S rRNA genes. The relative amount of 
reads of a specific 16S rRNA variant will correlate to the abundance of the corresponding 
bacterial species carrying that variant. One problem with this procedure is that only bacterial 
species that have been previously annotated and are present in the reference library can be 
identified in the sample in question. Fortunately, efforts such as the Human Microbiome 
Project have assembled such reference genomes for this purpose.  
3.2.5 VirScan 
VirScan is a phage display method for the detection of antibodies against the protein antigens 
of 206 viral species, essentially all viruses that are known to infect humans142. From these 
viral proteomes, linear stretches of 56 amino acids with an overlap of 28 amino acids are 
clonally expressed on the surface of bacteriophages, together constituting a library of linear 
peptide epitopes. Together harboring the coding sequences from all human viruses, this 
library of phages can be propagated and expanded in a bacterial culture. For antibody 
detection in a biological sample such as plasma, the phage library is incubated together with 
the sample, and antibodies are allowed to bind to the peptides expressed on the surface of the 
bacteriophages. Antibody-phage complexes are then precipitated using the Fc-binding Protein 
G coupled to magnetic beads. 
The antibody-bead complexes are washed and diluted in diH2O. The phages are lysed using a 
high temperature, and a PCR is run where the region coding for the clonally expressed 
peptide is amplified and sequenced. The reads are mapped to a reference database containing 
the genomes of all human viruses. The number of reads of a gene coding for a single epitope 
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will roughly correspond to the number of antibodies specific for that epitope(See 3.3.1 
VirScan Data Processing). 
3.3 STATISTICAL ANALYSIS 
A full mathematical description of all statistical methods employed in the papers constituting 
this thesis is far beyond the scope of this text. Rather, the goal is to try to give some intuition 
of the nature and purpose of each method with as little mathematical jargon as possible. 
3.3.1 VirScan Data Processing 
Each sample is processed and analyzed in duplicates. The reads from each duplicate are 
mapped separately to the full phage reference genome, and the number of reads mapped for 
each epitope is counted. The number of mapped reads is modeled using a zero-inflated 
Poisson distribution, and each duplicate is compared to the output of sequencing the full 
phage library. Based on this comparison, a p-value can be calculated for the enrichment of 
each epitope in the duplicates separately. An epitope is considered to be enriched if  
-log(p) > 2.3 in both duplicates. This generated a list of epitope hits. Epitope hits that were 
detected in the background library were removed (the background library was generated by 
sequencing phages mixed with beads without plasma). Finally, the VirScore is defined as the 
number of non-contiguous epitope hits per virus. 
3.3.2 Dimensionality Reduction 
In the context of biological data, a dimensionality reduction algorithm is the process of taking 
data sets where a large number of variables have been measured in a set of entities (e.g. cells, 
mice, test subjects, etc.) and creating a two-dimensional map of all entities where their 
positions and relationships to each other in some aspect reflects the structure of the original 
data set. There are many algorithms for dimensionality reduction, each with its own 
advantages and disadvantages. Here I’ve tried to explain the most important algorithms for 
dimensionality reduction used in this thesis. 
3.3.2.1 Principal Component Analysis 
PCA is a method for visualization of data sets with a large number of numerical variables. 
Based on the original variables, a new coordinate system with axes called principal 
components are produced. These axes are defined to describe as much of the variation in the 
data set as possible. To perform PCA, each variable needs to be centered, which is done by 
subtracting the mean. If the contribution of each variable is to be considered equally, they 
also need to be normalized to unit variance by dividing each variable by its standard 
deviation.  
The principal components can be established through a method called singular value 
decomposition. Briefly, each data point can be thought of as a point in multidimensional 
space where each variable corresponds to one of the axes of the coordinate system. The first 
principal component (PC1) is defined as the line that goes through the origin and has the best 
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fit for all points of the data set. The second principal component (PC2) is the line going 
through the origin with the best fit for all points of the data, provided that it is orthogonal to 
PC1. PC3 is defined in a similar way with the provision of being orthogonal to PC1 and PC2. 
This process can be continued until all principal components have been defined.  
The principal components can be thought of as new variables which describe the data better 
than the original variables. For visualization purposes, each data point can be plotted along 
the PC1 and PC2 axes in a new coordinate system and global structures taking all original 
variables into account can be observed in this way. Each principal component will describe a 
certain percentage of the total variation of the data, and it is possible that just two principal 
components give a relatively accurate description of the complete data structure, provided 
this number is high.  
3.3.2.2 Multidimensional Scaling/Principal Coordinates Analysis 
MDS is a group of dimensionality reduction methods that share the feature that they take as 
input a distance matrix with all pairwise distances between data points in a data set. The 
distances between two points are calculated based on the measured variables, and the method 
for measuring distance can vary. Based on the distances, a two-dimensional map of all data 
points is created, where the distances between the data points in the full data set are preserved 
as far as possible in the map.  
There are many different variants of MDS. Classical MDS is a subtype of MDS and is 
common in the field of biology, where it is sometimes referred to as PCoA. Classical MDS 
can use pairwise distance matrices calculated with a range of different distance functions. If 
Euclidian distance is used, classical MDS is identical to PCA. Its advantage lies in the 
possibility of using any function to calculate distances between data points. For example, in 
microbiome research, it is common to calculate microbiota composition as the relative 
frequencies of bacterial species. Euclidian distances are not ideal for calculating distances 
between such compositional data, and for this reason, other distance metrics such as the Bray-
Curtis distance are often applied to generate the distance matrix. Another useful distance 
metric in this context is UniFrac distance which also takes into account the evolutionary 
relationships between the different species. 
3.3.2.3 t-distributed Stochastic Neighbor Embedding 
The tSNE algorithm was developed with the specific goal of preserving the local rather than 
the global structure of data143. In other words, it gives more importance to accurately 
representing distances between points over short compared to long distances. This makes it 
particularly apt at visualizing data that exhibits a clustered structure, something very common 
in biological data sets. Like MDS, tSNE utilizes similarity between data points in high-
dimensional space to create a representative map in two-dimensional space.  
tSNE involves two types of similarity. One set of similarities consists of all pairwise 
similarities between points in high-dimensional space. The second set of similarities concerns 
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pairwise similarities between points in the resulting two-dimensional tSNE map. The 
similarity between two points is calculated by fitting a normal distribution with its center at 
point number 1 and calculating the corresponding value for the distribution at point number 
two. Because of the shape of the normal distribution, the similarity between two points taper 
off quickly as the distance between them increases. Technically, the normal distribution is 
only used for calculating pairwise distances in high-dimensional space. In the two-
dimensional tSNE map, distances are instead calculated using Student’s t-distribution (hence 
the “t” in tSNE). 
The points in the high-dimensional data set represent your actual biological data and are of 
course fixed. This also means that the distances between them are fixed as well, and only 
need to be calculated once. But what about the two-dimensional tSNE map which is the 
actual goal of the exercise? In the tSNE map, points are initially placed at random and all 
pairwise similarities are then calculated between them. The goal of tSNE is to make the 
discrepancy in pairwise similarities in the high-dimensional data set and the pairwise 
similarities in the tSNE map as low as possible. This discrepancy in similarity is determined 
by a measurement called Kullback-Leibler divergence. As data points are initially placed at 
random in the tSNE map, the discrepancy will be large at first. However, points are 
iteratively moved around in the tSNE map with the goal of minimizing the Kullback-Leibler 
divergence. This iterative movement of points in the tSNE map until the difference between 
the high-dimensional data set and the tSNE map is minimized is called gradient descent. 
When this process is over, the tSNE map is finished. 
3.3.2.4 Topological Data Analysis 
TDA is not a single algorithm for dimensionality reduction, but rather a field of research 
utilizing ideas from topology, as well as many other methods of data analysis, including 
algorithms for dimensionality reduction and clustering. For our purposes, the general 
procedure of TDA consists of subdividing the full data space into overlapping areas called 
bins. Within each bin, samples are clustered, and one cluster represents one node in the TDA 
network. As the bins partially overlap and clustering is performed within each bin, it is 
possible for a data point to belong to two different clusters/nodes at the same time. If this is 
the case, these nodes are connected with a dot. In this way, the final network is created. 
3.3.3 Clustering 
Clustering is the process of identifying groups of observations in a data set based on the 
measured variables. This can be done in two ways: unsupervised and supervised clustering. 
In unsupervised clustering, no information other than the values of the data points in the data 
set is used. For supervised clustering, information to aid in the clustering process is provided, 
such as already classified training data. Clustering has numerous applications in the analysis 
of biological data such as classifying cell types, identifying covarying groups of genes, and 
finding groups in a collection of samples or test subjects. 
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3.3.3.1 Clustering with Self-Organizing Maps 
SOM was developed by Teuvo Kohonen in the 1980’s144. SOM can technically be used both 
for dimensionality reduction and unsupervised clustering and is one of the most efficient 
algorithms for identifying cell populations in mass cytometry data145, which is also the 
primary application in this thesis. During SOM clustering of a high-dimensional data set, a 
network of points called nodes are placed in the space of the data set. The SOM algorithm 
iteratively goes through every data point several times. Each time, the closest SOM node and 
some of its neighboring nodes are moved closer to that data point. Eventually, the structure of 
the SOM network of nodes will approximate the structure of the full data set. Each data point 
is mapped to the closest node, and every node thus represents one cluster. In a SOM network, 
hundreds of nodes are often used for clustering. In the case of clustering immune cell 
populations, this is usually an overestimation of the total number of clusters in the data. 
Because of this, meta-clustering of SOM nodes is often performed to bring the total number 
of clusters down to a more reasonable number. 
3.3.3.2 Single-Cell Classification with Grid 
Mass cytometry data make up a large matrix where each row is a detected cell and the 
columns represent the analyzed parameters. One major application of mass cytometry is 
cellular phenotyping by the measurement of protein markers of cellular lineage, and the 
classification of cells based on these markers. As a mass cytometry data set often consists of 
more than 100 000 cells, and a project can involve the collection of more than 100 samples, a 
fast and accurate classification is important.  
Traditionally, the classification of such single cell data has been performed with the use of 
gating. Gating is the process of creating biaxial plots of two phenotypic markers and then 
classifying cells by drawing lines, or “gates”, around them. Analysis can continue by looking 
at different markers in the cells contained within each gate, and construct a hierarchical set of 
cell populations by the continued creation of gates. Considering a mass cytometry data set 
can easily consist of more than 40 markers, a major problem of this approach is simply the 
scope of fully characterizing all cell types in a large number of samples. In addition, the fact 
that classification is manual means that there is an inherent operator bias. 
Grid is a software for the manual classification of cells in mass cytometry samples, and the 
use of this information to automatically classify cells in new samples through the use of 
machine learning techniques. Cells are manually classified, not in biaxial gates, but in tSNE 
maps based on all measured protein markers (See 3.3.2.3 above). By making use of all 
markers, cell populations are much easier to distinguish. As more subtle variations between 
subpopulations of cells might not be apparent in a tSNE map of all cell populations, cells can 
be classified in a hierarchical fashion, analogous to manual gating in biaxial plots.  
In Grid, manually classified data serve as training data for several machine learning 
algorithms in order to classify new data sets. For simpler classification of easily distinguished 
populations, a linear regression model is sufficient. Classification of populations with more 
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subtle differences can be achieved with random forest and neural network algorithms. 
Internal validation using training and test data can be used to select the most optimal 
algorithm for each situation and we regularly achieved a classification accuracy of >95% for 
all cell populations. Summary statistics such as the relative frequencies of each population 
can be exported from the software. As single cells are classified individually, it is also 
possible to export all cells of a specific cell type and continue the analysis within this 
subpopulation. 
3.4 ETHICAL CONSIDERATIONS 
As always with research in humans, careful planning and consideration of ethical procedure 
in all aspects of conduct is an absolute requirement. All studies in this thesis are performed in 
accordance with the declaration of Helsinki and have the proper approval of local ethical 
committees. Here I will discuss what I believe to be the three most important ethical issues 
with regards to the four papers that make up this thesis. These are:  
1. The psychology of enrolment in clinical studies 
2. The special issues that arise with sampling of children 
3. The ethical requirements on proper storage of data 
Study subjects in the cohort studied in paper I & II were enrolled in the days following birth 
that the parents spend at the hospital. This was an absolute requirement for this cohort, as it 
includes many very preterm babies that are sometimes emergency deliveries. Also, as 
sampling starts immediately at birth, it is important that inclusion in the study happens as 
soon as possible. In contrast, the mothers in paper III & IV were recruited during pregnancy 
in the healthcare centers or maternity wards. Regardless of where participants are recruited, it 
is important that they are in a position where they can evaluate all information regarding the 
study calmly and carefully. It is also vital that they don’t feel any pressure to participate, or 
that their decision will affect the type and quality of care they or their child is given, 
especially for the parents of very preterm children who often stay for weeks or months in the 
hospital following birth. It is important that the parents are aware of what the study will entail 
for them and their children. They need to know what will be done with the results of the 
study, and that they can drop out of the study at any time without consequences. All this 
information and more is provided when families are recruited. 
All studies in this paper are conducted in children. In addition to the regular considerations 
that need to be taken for blood sampling in adults, the sampling of children presents 
additional ethical and moral problems. Taken together, the studies in this thesis have 
collected several hundred blood samples at the ages of 0 to 5. Newborn children obviously 
cannot consent to sampling, and it is up to the parents to make the decision for them. As the 
blood volumes are very small, and collection is usually performed by simply piercing the skin 
with a needle, the physical harm and emotional stress of the child is considered to be 
minimal. As children age, their conceptual understanding of the sampling procedure 
increases. Even before they are able to verbally protest, they can show apparent resistance to 
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sampling. This is ameliorated by the use of local anesthetic cream, having nurses trained in 
working with children, and having toys and other distractions for the child. As sampling in 
older children is done by venipuncture, it is important that the child is reasonably calm at the 
time of sampling, and sampling will not be attempted if this is not the case. At the age of 5, 
the child is able to verbally protest. If they do, sampling is not performed, although this is 
rarely the case if sampling is performed by a trained nurse. All these considerations have 
been made and followed in the three cohorts that are discussed in this thesis. 
Studies in humans often involve the collection of sensitive data. This entails strict care in 
deciding which parameters are to be collected, as well as special considerations as to the 
storage and access to the data. Since the introduction of the GDPR regulations, these rules 
have become even stricter. The most important precaution is the coding of data, referring to 
the representation of each study participant by a study ID. This study ID can only be related 
to the personal number of the study participant by the use of a key which is only accessible 
by one or a few people in charge of the study. Despite this, as we collect large amounts of 
information about each study participant, the information in itself might be enough to 
positively identify a person. For example, information about the birth hospital, day, and time 
could be enough to identify an individual by someone with access to the hospital birth 
records. For this reason, it is also important that all data is kept under strict access. For the 
data in paper I & II, such information is kept in a database managed by us with access only 
for people working directly with the data. This is done for all data and metadata, including all 
data files, processed data, all information collected during site visits, as well as from health 
records. Specific authorization is required for the extraction of information from the database 
to a local computer. The cohort information in paper III & IV is stored in a similar way, 
although those databases are not curated or managed by us. In all studies, it is important that 
the participants are made aware of what data is stored, how it is stored, and how it is used. 
 
4 RESULTS 
The results and conclusions of each paper will be presented separately and a synthesis of all 
papers will then be attempted in the discussions-section. 
4.1 PAPER I 
This study looked at the development of the human immune system in a cohort of newborn 
term and preterm children. To study this, we measured immune cell composition using mass 
cytometry, plasma protein concentrations with PEA, and gut microbiota composition with 
16S rRNA sequencing in samples taken from birth up until as late as 6 months of age (Figure 
2). The main finding of the study was the fact that while preterm and term children were very 
different at birth, after 3 months of life they had developed towards a similar phenotype with 
regards to immune cell composition and plasma protein concentrations. We hypothesized that 
this development could be partially driven by impinging environmental factors, and we could  
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Figure 2 Graphical abstract from paper I. 50 preterm and 50 term children and their parents 
were sampled from birth until approximately 3 months of age. Immune cell composition was 
measured with mass cytometry, plasma protein concentrations were measured with PEA, and 
gut microbiome composition was measured with 16S rRNA sequencing. Reprinted with the 
permission of Cell Press. 
 
see that children with gut dysbiosis closely after birth had a smaller degree of convergence 
compared to children with a more diverse microbiota. 
To get an overview of the global structure of immune system development in our cohort, we 
used topological data analysis (TDA). It is a dimensionality reduction algorithm which has 
the strength of being able to integrate different data types and generate a network of samples 
that can then be investigated (Described more extensively in 3.3.2.4). We found that cord 
blood samples of both term and preterm children formed their own separate cluster, 
indicating the qualitative differences between cord blood and peripheral blood (Figure 3, left 
panel). Also, samples taken earlier in life were separated from samples taken at three months 
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of age, with samples taken early in life in the left part of the network and samples taken later 
in the right part of the graph. The two arms in the left part of the network mainly represented 
samples from term or preterm babies respectively, indicating the immunological differences 
present between these groups early in life (Figure 3, right panel). However, in the right part of 
the graph, representing samples collected later in life, samples from term and preterm 
children were part of the same nodes, indicating immunological convergence. 
 
Figure 3 TDA network of all children’s samples. Similar samples are grouped into nodes in 
the network based on immune cell composition and plasma protein concentrations, and a 
sample can be part of more than one node. If nodes share a sample, they are connected with a 
line, which means that similar nodes end up close together in the network. The nodes of the 
left network are colored by the average age of sampling in days for all samples in the node. 
The right network is colored based on the average gestational age at birth of the children from 
which all samples in the node are taken. Reprinted with the permission of Cell Press. 
Next, we wanted to identify which immunological phenotypes were associated with the 
different parts of the network. We divided the network into 5 parts representing different 
stages of immunological development (Figure 4A). When looking at all pairwise inter-sample 
distances within each part of the network, we could see that the differences between samples 
decreased over time, both in terms of plasma protein concentrations (Figure 4B) and immune 
cell composition (Figure 4C). To try to identify some of the immunological processes 
correlated with these changes, we looked at the concentrations of individual proteins. The 
immunosuppressive protein IL-10, as well as its inducer IL-27, were high in cord blood, 
immediately dropped after birth, and then slowly increased (Figure 4D). The very high levels 
in cord blood possibly reflect the immunosuppression required during the fetal stage of 
development. At later time points, there was also an increase of soluble PIgR, a protein 
required for transport of IgA across the mucosal membranes. The levels of IL-8 had 
decreased at 3 months of age, whereas the levels of IL-17A and IL-12B increased in 
peripheral blood. IL-8 has previously been reported to be an important effector mechanism of 
early life immunity146. In contrast, IL-17A and IL-12B are associated with the differentiation 
of the more traditional T helper cell subsets Th17 & Th1 cells respectively. However, the 
large difference in concentration in cord blood is harder to explain and might represent more 
complicated aspects of the functions of these cytokines. 
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Figure 4 A) The TDA network from Figure 2 divided into 5 areas representing 5 sample 
groups. B-C) All pairwise inter-sample distances for samples within each of the 5 groups in 
A) for plasma proteins (B) and immune cell composition (C). D-F) Plasma protein 
concentrations in the 5 groups in A) for proteins IL-27 and IL-10 (D), PIgR (E), IL-8, IL-
17A, and IL-12B (F). Reprinted with the permission of Cell Press. 
Finally, we looked at changes in gut microbiota composition in relation to immune phenotype 
over time. In a principal coordinates analysis of all individuals (described in more detail in 
3.3.2.2), we could see that samples clustered by time point and that earlier samples exhibited 
larger inter-individual variation (Figure 5A), something that has been described previously37. 
We could also see that gut microbial diversity increased over time (Figure 5B). We identified 
a dysbiotic subset of children that exhibited unusually low microbiota diversity during the 
first month of life (Figure 5B, orange). We compared these to children with a more diverse 
microbiota and could see that the degree of immune cell composition convergence observed 
later in life (Figure 4C) was higher in subjects with a more diverse microbiota (Figure 5C). 
 
 
Figure 5 A) Principal coordinates analysis of all gut microbiota samples colored by time 
point of sample collection. B) The age at sampling collection in days plotted against Shannon 
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a diversity for all gut microbiota samples. A linear trendline with the confidence interval is 
shown. Samples from individuals classified as having a microbiota that is dysbiotic (orange) 
or diverse (purple) are also indicated. C) All pairwise interindividual distances based on 
immune cell composition for individuals classified as dysbiotic (orange) or diverse (purple). 
Reprinted with the permission of Cell Press. 
4.2 PAPER II 
In this paper, we studied maternal antibodies in term and preterm children (Figure 6). We 
included 78 mother-child dyads where we collected blood from the mother, and also cord 
blood from the child and peripheral blood at approximately 1, 4, and 12 weeks of age. 
Antibodies against 206 human viruses were detected on an epitope level using the phage 
display method VirScan. Based on all detected epitopes, a VirScore is calculated for each 
virus, representing the complete antibody repertoire against that viral proteome.  
We compared VirScores for the first sample taken from each child (Figure 7). In most cases, 
this was a cord blood sample, but in some cases a peripheral blood sample collected during 
the first few days of life. However, there were no obvious differences between these tissues. 
The repertoires were comparable between the preterm and term children, indicating that 
placental antibody transfer takes place as early as gestational week 24. The most common 
viruses to have antibody protection against included common latent viruses such as HHV-1 
(HSV-1), HHV-4 (EBV), and HHV-5 (CMV), as well as viruses that generate acute 
infections such as Rhinovirus A, and B as well as Influenza.   
 
 
Figure 6 Graphical abstract of paper II. Plasma samples were collected from mothers and 
children from birth up until 3 months of life. 514 samples from 78 mother-child dyads were 
collected. The antibody repertoire against 206 different viral species was analyzed using 
VirScan. Reprinted with the permission of Nature Publishing Group. 
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Figure 7 Calculated VirScores against the top 44 most common viruses from the first 
available sample (always within 3 days of birth) from all 78 children. Gestational week at 
birth and whether the source is cord- (white) or peripheral (grey) blood is indicated at the 
bottom. Reprinted with the permission of Nature Publishing Group. 
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Figure 8  A) Pearson’s correlation between viral genome size and the number of detected 
epitopes for each virus. B) Heatmap of statistical significance of enrichment for antibodies 
against all epitopes of the RS-virus major surface glycoprotein G in all samples. C) The 
percentage of samples seropositive for antibodies against each epitope separately for the top 
44 most common viruses. The earliest available sample for each child was used. UniProt ID 
and amino acid numbers are shown for peptides targeted in >50% of all children. Reprinted 
with the permission of Nature Publishing Group. 
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Next, we wanted to determine antibody specificity on an epitope level. The size of the viral 
genome correlated with the number of epitopes detected for each virus (Figure 8A). This is 
likely due to the simple fact that a larger virus have more proteins for the immune system to 
target. For some viral proteins, there are preferred targets, so-called immunodominant 
epitopes. For example, the plasma of both mothers and children were enriched for antibodies 
against an epitope located between amino acid 141 and 224 in the RSV major surface 
glycoprotein G (Figure 8B). The identification of such immunodominant epitopes could be 
important for vaccine development. We plotted the occurrence of antibodies against each 
epitope as a percentage of all children for the most common viruses (Figure 8C). The number 
of immunodominant epitopes (defined as an epitope targeted in >50% of all samples) varied 
between viruses. Such a list could be used to identify potential targets for immunization, but 
also to elucidate mechanisms behind immunodominance in humoral immunity. 
 
Figure 9 A-C) Scatter plots of antibody concentrations determined by ELISA in mothers on 
the x-axis and their newborn children on the y-axis for CMV (A), EBV (B), and RSV (C). D) 
Explained sum of squares for birth weight, gestational age, and maternal antibody 
concentration and residual sum of squares in an ANOVA model predicting newborn antibody 
concentrations against CMV, HSV1, EBC, Influenza A, and RSV. Reprinted with the 
permission of Nature Publishing Group. 
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Finally, as VirScores do not necessarily correlate perfectly with antibody titers, we also 
determined the concentrations of antibodies against a few of the most common viruses in 
both mothers and children using standardized ELISA assays. The most important determinant 
of newborn antibody concentrations in our samples was maternal antibody concentration. 
However, the degree of correlation varied a lot between viruses, with viruses like CMV 
(Figure 9A), and EBV (Figure 9B) having a relatively high correlation, and RSV having 
lower correlation (Figure 9C). In an ANOVA model, maternal antibody concentration 
explained a majority of all variance in CVM and HSV1. In RSV it only explained a small part 
of all variance and >75% of all variance could not be explained by any of the factors in the 
model (Figure 9D).  
4.3 PAPER III 
In this paper, the goal was to study the impact of the environmental exposures and lifestyle on 
the immune system of children growing up in anthroposophic families. Among other things, 
the anthroposophic lifestyle is characterized by home delivery, prolonged breast-feeding, an 
organic diet, and a reluctance to take antibiotics and submit their children for vaccination 
(Figure 10A). We collected blood samples from mothers during pregnancy, and from the 
children at birth, and at 2 and 5 years of age. We determined immune cell composition and 
cytokine production capacity in response to stimulation with mass cytometry (Figure 10B).   
 
Figure 10 Graphical abstract for paper III. A) Children with a conventional western lifestyle 
were compared with children growing up with an anthroposophic lifestyle which includes 
extensive use of wool clothing, a longer period of breastfeeding, and a reluctance to vaccinate 
or take antibiotics. B) PBMCs were collected from mothers during pregnancy, as well as 
from the children at birth and the ages of 2 and 5. Cells were used for phenotyping and 
functional assays of cytokine production with mass cytometry. 
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First, we wanted to look at changes in immune cell composition from birth up until 
adulthood. As we observed no apparent differences between control and anthroposophic 
children at this point, we analyzed these samples together at this stage. Although the gaps in 
time between samples are quite large, there are clear changes over time. For the major 
immune lineages, the clearest patterns are high levels of B-cells at 2 years of age and a 
dramatic increase in monocytes somewhere between the ages of 5 years and adulthood 
(Figure 11A). As the T-cells are a very heterogeneous population, we also looked at the 
relative frequencies of the major subpopulations within the T-cell population (Figure 11B). 
The most obvious pattern here is a decrease in cells with a naïve phenotype and a converse 
increase of memory populations. Less apparent changes were also present in basophils 
(Figure 11C), CD56bright NK-cells (Figure 11D), myeloid DCs (Figure 11E), and 
plasmacytoid DCs (Figure 11F). 
 
Figure 11 A-B) Immune cell composition of the major lineages (A) and within T-cells (B). 
C-F) Immune cell frequencies of basophils (C), CD56bright NK-cells (D), myeloid DCs (E), 
and plasmacytoid DCs (F). Samples from the same child and its corresponding maternal 
sample are connected with grey lines. A linear trend line in black with confidence interval is 
superimposed on the data. G) MDS plot based on immune cell frequencies for all samples. 
Samples are colored based on the sampling source and time point. A pseudo-time axis present 
in peripheral blood samples along the y-axis is indicated with an arrow. H) The correlations 
of the frequencies of three different SOM clusters with the MDSy-axis in G).  
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While the manual definition of cell types through gating is more biologically interpretable, it 
comes with the risk missing less well-defined populations or populations that are hard to 
discern when only looking at two markers at the same time. We applied SOM clustering to 
the cells of 6 major lineages in each sample, in order to detect immune cell types in an 
unsupervised manner (see 3.3.3.1 for details). We performed multidimensional scaling on the 
Aitchison’s distance matrix between samples (Figure 11G). Cord blood separates clearly 
from peripheral blood, and the peripheral blood samples form a pseudo-time trajectory along 
the MDSy-axis. Interestingly, the separation between samples and the time trajectory were 
much clearer when using SOM cluster data compared to using manually gated data (not 
shown). To identify which populations were associated with the age trajectory in Figure 11G, 
we calculated correlations between SOM clusters in all peripheral blood samples and the 
MDSy-axis (Figure 11H). The highest correlation was a positive correlation with B-cell SOM 
clusters and a negative correlation with CD14+ monocyte SOM clusters. However, these 
clusters did not really have any unusual phenotypes and likely represent the same phenomena 
that can be observed in Figure 11A. 
While immune cell composition and phenotyping reflect part of the immune competence of 
an individual, it does not reveal the full functional capacity of the cells. Next, we looked at 
cytokine production in response to stimulation with PMA and ionomycin together with 
inhibitors of protein secretion. Cells were fixed after stimulation, stained intracellularly with 
antibodies against a panel of cytokines, and analyzed with mass cytometry. The percentage of 
cells positive for each cytokine and combinations of cytokines was determined for CD4+- and 
CD8+ T-cells, NK-cells and monocytes and used for all subsequent analyses.  
A PCA was performed based on data collected from 4 anthroposophic and 4 control children 
(Figure 12A). While cord blood samples clustered close together in PCA-space, later time 
points were more spread out, indicating increased heterogeneity over time. When separating 
samples by lifestyle, 3 anthroposophic children followed a similar trajectory along the PC2-
axis (Figure 12A, left). In contrast, 1 anthroposophic child, as well as all control children, 
followed another trajectory along the PC1 axis (Figure 12A, right). To identify which 
phenotype was associated with the different trajectories, we looked at the loadings of the 
principal components (Figure 12B). Trajectory 1 is associated with a decrease in TNF 
production in T- and NK-cells, while Trajectory 2 depicts a decrease in the production of IL-
2 and IFNg in T-cells. Both trajectories are associated with an increase in the production of 
IL-17A in T-cells. These differences are especially clear at the age of 5 (Figure 12C-E). 
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Figure 12 A) Principal component analysis based on levels of cytokine production in the 
major immune cell lineages of 8 selected children as measured by mass cytometry. 
Anthroposophic and non-anthroposophic children are shown separately. Samples from the 
same individual are connected with lines and samples are colored based on age at sampling. 
Pseudo-time trajectories along the two principal components are indicated with arrows. B) 
Loadings for the two principal components shown in A). Factors are colored based on their 
total contribution. C-E) Differences in expression levels of IFNg (C), IL-2 (D), and TNFa 
(E), in CD4+ T-cells at the age of 5. Samples are separated by trajectories as in A). 
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4.4 PAPER IV 
In paper IV, the aim was to prospectively track the impact of environmental influence on the 
immune system of 1-year-olds (Figure 13A). 101 mothers and their children were recruited 
during pregnancy and were asked to regularly fill in a questionnaire on lifestyle factors of the 
child such as diet, medication, disease, etc. This information was complemented with 
anthropometric data from site visits and clinical data. We collected a blood sample at 12 
months of age and analyzed immune cell composition with mass cytometry.  
As mass cytometry data analysis can be time-consuming for large data sets, we developed 
Grid, a machine-learning classifier which classifies single cells based on marker expression 
(More details in 3.3.3.2)(Figure 13B). Grid uses data that has been manually classified by 
gating on tSNE maps as input. It then uses this information to classify new data sets. The 
classification algorithm can be chosen depending on the population that is to be classified and 
includes algorithms such as linear regression classifiers, random forest, and neural network 
algorithms. As mass cytometry includes the measurement of >40 markers, we were able to 
perform classification of 28 cell types with an accuracy of over >95% for every cell type. 
 
 
Figure 13 Graphical abstract for paper IV. A) Information about environmental factors, 
lifestyle, and disease was collected through a series of questionnaires and site visits from 
families recruited during pregnancy. Blood samples were collected from children when they 
were 1 year old. Immune cell composition was analyzed with mass cytometry and the results 
were related to the collected metadata. B) To calculate immune cell composition, single cells 
in the mass cytometry data were classified using Grid, a software we developed for this 
purpose. Manually gated data is used to train an unsupervised deep learning algorithm that 
can classify single cells in new mass cytometry data sets with an accuracy of >95% for every 
cell type. 
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We used Grid to classify cells from all samples and calculated relative frequencies of immune 
cell populations (Figure 14A). On average, T-cells were the largest lineage, followed in order 
by granulocytes, B-cells, monocytes, and NK-cells. The range of composition of the various 
immune lineages varied substantially between children (Figure 14B). One tradeoff is between 
higher levels of granulocytes and monocytes against T- and B-cells. A similar range of 
variation is also present in the subpopulations for each lineage (Figure 14C-G). For example, 
the range of naïve T-cells goes from just over 50% to 85%. Similarly, the frequency of 
CD56bright NK-cells varies from 5-39%, an almost 8-fold difference.
  
Figure 14 A) The mean frequencies of five immune lineages in blood as a percentage of all 
white blood cells in children are shown in the center. The pie charts around it depict the mean 
relative frequencies of subpopulations within each lineage. B) Bar charts of immune cell 
frequencies in all 101 samples sorted by similarity. Colors and populations are the same as in 
A). C-G) Bar charts of relative immune frequencies within T-cells (C), granulocytes (D), B-
cells (E), monocytes (F), and NK-cells (G) in all 101 samples. Populations and color codes 
are the same as in A). 
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As all samples are taken at approximately 12 months of age, we can get a good estimate of 
interindividual variation at this time point. We wanted to set this in perspective to the adult 
phenotype, and compared the relative frequencies of the major immune cell lineages in 
peripheral blood between our samples from children and a cohort of adults we have collected 
for a previous study135. There were large differences between the immune cell composition of 
children and adults, the most important being a higher frequency of neutrophils in adults and 
lower frequencies of all other immune cell lineages (Figure 15A). To get a global overview of 
these differences, we performed MDS on the pairwise Aitchison’s distance matrix of all 
children and adults (Figure 15B). Samples from children separate almost perfectly from 
adults, indicating the qualitative difference in immune cell composition. Also, the adult 
samples are spread over a larger area compared to samples from children, indicating a larger 
degree of interindividual variance. Indeed, when comparing the pairwise Aitchison’s 
distances for children and adults, the average distance is higher in adults. This highlights the 
increase in interindividual variation with age that has been described previously for immune 
cell composition147, as well as other aspects of the immune system148. 
 
Figure 15 A) The frequencies of six major immune lineages in blood as a percentage of all 
white blood cells in children and adults. B) Multidimensional scaling plot based on immune 
cell composition of 8 cell types. Samples are colored based on whether they come from 
children or adults. C) Violin plots of all pairwise inter-sample distances within children and 
adults separately. Inter-sample distances are calculated with the Aitchison’s distance metric. 
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Finally, we wanted to use the metadata collected so far to see whether we could find any 
connections between early-life environmental exposure and immune phenotype. One of the 
differences found was related to the administration of prenatal antibiotics. Children whose 
mothers received prenatal antibiotics had lower frequencies of CD4+ memory cells and class-
switched memory B-cells (Figure 16A). In paper I we observed that early-life dysbiosis was 
associated with higher inter-sample distances at approximately 3 months of life135. Here, we 
saw that children who received prenatal antibiotics also exhibited higher inter-sample 
distances at the age of 12 months (Figure 16B). We have not yet analyzed the data on the 
early-life gut microbiota in this cohort, so it remains to determine whether we are observing a 
similar phenomenon, but it is of note that prenatal antibiotic exposure has been observed to 
affect the neonatal microbiome in mice149 and humans150, although the importance of such 
influence remains to be established. 
 
Figure 16 A) Relative frequency of central- and effector memory CD4+ T-cells and IgD- 
memory B-cells in all children, split up based on whether their mothers received prenatal 
antibiotics. B) Violin plots of all pairwise interindividual distances between immune cell 
composition, as measured by Aitchison’s distance within each group in A). 
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5 CONCLUSIONS 
Here I will summarize the most important findings from each paper of this thesis. Naturally, 
any attempt to condense a scientific study into a few sentences will leave out important 
details. Rather than trying to give a comprehensive description of all consequences of the 
results in each paper, I will simply list some of the most important conclusions drawn from 
the data. 
Paper I 
The cord blood of preterm and term children were found to be radically different both in 
terms of immune cell composition and plasma protein concentrations. Cord blood was also 
shown not to be representative of postnatal peripheral blood in immune cell composition, 
immune cell phenotype, or plasma protein concentrations. Both preterm and term children 
exhibited larger variation in immune cell composition compared to adults, and there was a 
clear patterned progression of change in immune cell composition over time. The infant 
immune cell phenotype is moving towards a parental phenotype for some populations, but not 
for others. In an integrative analysis of immune cell composition and plasma protein 
concentrations, preterm and term phenotypes were shown to be different at birth but then 
converged later in life. In this analysis, inter-individual differences decreased over time, 
which were correlated to changes in microbiota-related cells and proteins. Finally, gut 
microbiome diversity was seen to increase over time, and a subgroup of neonates with 
dysbiosis was shown to have a lower degree of convergence of immune cell composition 
compared to children with healthy gut microbiota.  
Paper II 
Most parents had antibodies against between 5-10 viruses. Preterm and term children had 
similar antibody repertoires at birth and there were no differences in antibody repertoire 
between cord blood and peripheral blood taken shortly after birth. The neutralizing capacity 
of plasma from preterm and term children against RSV and Influenza A was similar as well. 
The number of epitopes targeted with antibodies per virus correlates with viral genome size. 
The number of immunodominant epitopes (detected in >50% of seropositive children) varied 
a lot between viruses. For some viruses, there were strong correlations between the maternal 
and newborn antibody concentrations. For other viruses, most of the variation in newborn 
antibody concentration was unexplained. 
Paper III 
There is a progression of changes in global immune cell composition and T-cell phenotype 
from birth via the ages of 2, and 5 to adults. Cord blood was shown to be qualitatively 
different in terms of immune cell composition, and within the peripheral blood samples, there 
is an ageing trajectory. CD4+ and CD8+ T-cells, B-cells, and NK-cells, but not monocytes, 
exhibited changes towards a maternal phenotype. There were temporal changes in immune 
cell function, and the number of multifunctional T-cells increased over time. In a PCA plot 
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based on cellular cytokine responses, children followed two separate trajectories. The main 
difference found between trajectories were the number of vaccination doses. 
Paper IV 
Immune cell populations in single-cell mass cytometry data could be accurately classified 
with the Grid software using machine learning and already classified training data. The range 
of interindividual variation in immune cell frequencies in 1-year-olds was large, both for the 
major immune cell lineages and for the subpopulations within each lineage. There were large 
differences in immune cell composition between children and adults, and the interindividual 
variation was even larger in adults than in children. Children whose mothers were 
administered prenatal antibiotics had lower levels of CD4+ and CD8+ T-cell and B-cell 
memory populations. They also exhibited a larger degree of interindividual variation. 
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6 DISCUSSION 
In this thesis, I hope to have shown that the immune system of the developing infant is 
influenced by external factors, meaning any cause of change in the immune phenotype 
physically originating from outside the body. I believe this statement in itself to be 
completely non-controversial. It has already been demonstrated numerous times before, and I 
think any serious immunologist must hold the statement to be almost self-evident. What is 
still under debate, and will remain so for the foreseeable future is specifically which external 
factors are important, how important they are, which components of the immune system they 
influence, and how they assert this influence. The prospects of definitively answering any of 
these questions are, at the moment, not very good. The almost unimaginable range of 
variation in lifestyle, environmental exposures, genetics, and immune phenotype in human 
populations around the globe is daunting. In addition to this, studies might differ in their 
results due to the choice of analysis method, reagents, experimental protocol, data analysis, 
etc. In the light of all of these sources of variation, can we ever hope to find conclusive 
answers to the questions on the nature of external influence on immune system development? 
About two years ago, a comment in Nature was published, describing the agonizing progress 
by three separate labs of trying to repeat the results of a paper on the use of superoxide 
dismutase/catalase mimetics to extend the lifespan of the nematode Caenorhabditis 
elegans151. By years of work and long meetings, they were able to standardize the assay to a 
degree where they achieved comparable results. A similar article in Cell Reports from 2014 
describes the efforts made by two labs to standardize a flow cytometry assay152. Such 
publications are exceedingly rare, probably due to the expenses in time and money to perform 
standardization experiments combined with the reluctance of academic journals to publish the 
results as actual research articles. As it turns out, small differences in experimental protocols 
can lead to huge disparities in results, even when studying relatively simple biological 
systems. Efforts to standardize protocols between labs are sometimes made, and such efforts 
should be commended. However, it is still the case that there is no consensus in the field of 
human systems immunology in terms of how to collect and store samples, what experimental 
protocol to use for each assay, which reagents to buy, and how to process, analyze and 
interpret data. 
In my mind, one strength of this thesis is at least the inception of an attempt to apply 
standardized methodologies for the study of the human immune system. While several 
aspects of the study in paper III were out of our hands, we tried to employ standardized 
protocols for every step from sample collection to data interpretation in paper I, II, and IV. 
For example, although paper I and IV were conducted in different countries by different 
people, we were still able to standardize the whole blood phenotyping by mass cytometry in 
terms of sample collection and storage, thawing, post-thawing processing, barcoding, staining 
(using the same phenotyping panel), sample acquisition (using the same mass cytometers), 
data preprocessing, and automated gating. We made important developments in this area 
including a protocol for preservation of white blood cells, setting up part of the protocol on a 
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robot platform153, and automating the single-cell classification of mass cytometry samples 
with the Grid software. 
After adding even more samples than we analyzed in the published paper, we are able to 
integrate all peripheral blood samples collected in both studies thus far and show the 
development of immune cell composition (Figure 17). In light of the discussion above, it is 
important to remember that analyzing the huge amount of variation observed between 
individuals, as well as over time, will be a monumental challenge. Nevertheless, it is 
encouraging that patterns in the data can still be discerned. For example, at the approximate 
age of 1-2 months, there is a drastic increase in the number of B-cells in peripheral blood that 
occurs consistently in all children, regardless of preterm/term status, or any other variable we 
have looked at so far (Figure 17,  arrow). This is possibly related to the increase in B-cells 
previously reported in infants94–98. By standardizing procedures, the amount of variation due 
to technical noise can be decreased, and the power to detect a biological signal increases. As 
is obvious from Figure 17, there is a large amount of variation that remains to be explained. 
Some of this variation will be biological and some will be technical. We can only do so much 
to decrease the amount of technical variation, but by continuously collecting samples, and 
carefully annotated metadata, we can begin to deconvolute the effects of different sources of 
variation such as mode of delivery, gestational age at birth, diet, the gut microbiota, and of 
course, genetics. 
  
Figure 17 The upper panel shows bar charts of the immune cell composition of 387 
peripheral blood samples from children sorted by age from left to right. A point of drastic 
change in immune phenotype is indicated with an arrow. The lower panel indicates the age at 
sampling in days for each sample in the upper panel. Samples are colored based on which 
study they belong to. 
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Standardization is important to remove technical errors introduced by differences in sampling 
protocol, data analysis, etc., but what about technical noise inherent in the actual 
experimental measurement itself? Any experimental measurement will include some margin 
of error. The size of this error factor will vary between measurement technologies. For 
example, while the measurement of the expression of a single gene with qPCR always 
involves some error due to the experimental method and the stochastic nature of gene 
expression, measuring global gene expression with mRNAseq will yield more stable results. 
While the measurement of the expression of a single gene with mRNAseq might be 
inherently noisy, the expression of gene modules, collections of genes with similar behavior, 
is more stable154,155. Another advantage of collecting more comprehensive data is the 
possibility to calculate higher-order metrics. Calculation of changes in gene- or protein 
modules is one example of such higher-order metrics. Other examples include the calculation 
of inter-sample Aitchison’s distances based on the complete immune cell composition, or the 
calculation of microbial diversity based on the composition of microbes in fecal samples.  
The presence of large amounts of environmental and genetic variation in human systems 
immunology research could be viewed as a weakness compared to studies performed in mice. 
Above I argued that on the contrary, such variation could even be advantageous68, and that 
appreciating it is a necessity if we are ever to successfully study and treat complex immune-
mediated human diseases, or effectively and safely develop and apply novel 
immunotherapies. What any immunologist should be able to agree on is that such variation 
presents difficulties. Because of this, all studies in this thesis will sometimes be plagued by 
the consequences of such variation including high p-values, poor correlation, outliers, and 
difficulties with reproducibility. In addition, as in any systems immunology study in humans, 
there will be high costs, missing data, dropouts, batch effects, bias, insufficient numbers of 
participants, and abstract or complex results. Many or all of these could be considered 
weaknesses of this thesis, but also challenges that need to be overcome. The field is still in its 
inception, and I feel we have made a decent job to address at least some of these issues, while 
most of the work, of course, still remain.  
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7 FUTURE PERSPECTIVES 
One of the reasons for why science is so hard is because reaching an understanding of a 
scientific process does not only involve the actual scientific study of the process, but also the 
metascience, the study of how to study that process scientifically. This harks back to the 
introduction, and the concepts of reductionistic and holistic approaches to the scientific 
process. While useful, these concepts are still relatively vague notions, and their use in 
guiding concrete choices of scientific methodology in a specific field is limited. Thus, new 
paradigms of method and conception within most scientific fields still develop via a process 
of trial and error rather than any guiding overarching principle. Every scientific field is 
different, and part of the scientific process will always consist of establishing which methods 
will be successful to uncover new information in that particular area.  
Giving extra thought to scientific method might be particularly advantageous within the field 
of human systems immunology. I see at least four reasons for this: 
1. It is a relatively new field, which means that there are few established research 
methodologies in place, to begin with. 
2. As described previously, the experimental method is one of several sources of 
variation and bias in systems immunology data. 
3. It requires cooperation between people with diverse backgrounds and skill sets, 
including physicians, nurses, biomedical researchers, lab technicians, 
bioinformaticians, and mathematicians. 
4. As many would consider conceptual understanding to be one of the goals of the 
scientific enterprise, the human immune system could present a challenge in the sense 
that there is a possibility that we might never be able to understand it at all. It is 
amazing how we have evolved to be able to comprehend so much of the physical 
world, considering that there is no obvious evolutionary advantage in doing so. 
However, this also means that we can never assume that our brains are capable of 
understanding everything about the physical world. Indeed, our understanding of 
things like 10-dimensional space or quantum processes is only mathematical and not 
intuitive. In this sense, the field of biology is lagging behind physics, and there is a 
real possibility that a full conceptual understanding of the immune system, and 
probably other parts of biology as well, will never be more than mathematical. 
In relation to these challenges, I will attempt to outline some thoughts on how I believe the 
studies presented in this thesis could be taken even further. 
As sources of variation are ubiquitous within systems immunology data, efforts for 
standardization of methods will be important. Not only within a research group but ideally 
throughout the field. Standardized protocols for collection, processing and storage of 
biological samples will be important. For example, both pre-centrifugation delay156 and 
storage time157 have been shown to have effects on plasma protein concentrations. These 
effects are important as they not only introduce random noise into the data but can bias a 
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whole study. While complete agreement within the field on optimal procedures might be 
unfeasible, it is at least important to be aware of these effects. As recruitment and sample 
collection continues for both the TELLUS and PreventADALL cohorts, continued work in 
standardization is required. Also, it is vital to track changes in protocols throughout the study 
to ensure that samples from different time points are comparable. 
Furthermore, differences in data analysis is another source of variation in systems 
immunology data. Many different tools and methods for the preprocessing and analysis of 
omics data have appeared in the last few years, but there is no consensus on which tools, 
methods and statistical tests to use. Differences in data preprocessing, analysis and 
presentation will make it harder to compare data between labs, especially if the raw data is 
not available. Ideally, both the raw data as well as code for all preprocessing should be 
available. This would facilitate the publication of meta-analyses of systems immunology data 
as well. While repositories for such data are available158,159, the number of publications 
resulting from the analysis of such data is not very large. This might be due to that 
insufficient metadata is available, or that the variation between experiments is too large. In 
the continued work with our cohorts, we will aim for full transparency in experimental 
method and data analysis, although we are not there yet. 
An important aspect of my time as a Ph.D. student has been being a part of a larger network 
of individuals working together to conduct systems immunology studies. The design of such 
networks, meaning making decisions on who to hire and who should be working together and 
how, is no easy task. Throughout any research project in systems immunology, establishing 
standard operating procedure will be an inherent part of the work, and effective 
communication between people of different specializations is key. For example, establishing 
optimal protocols for sample collection will require both inputs from the clinical staff 
performing the sample collection and processing, but also from the lab technician acquiring 
the sample and the data analyst looking at the results. Another example is the collection of 
metadata in curated databases which requires input from the clinicians who will enter the 
information, the data analyst who will use it in the statistical analysis, and the programmer 
who will build the database. Enabling efficient communication between the different parts of 
any research effort is important in general, and for systems immunology research in 
particular.  
The nature of the scientific study and understanding of the human immune system, and 
different approaches to describing it, is a subject for a thesis in itself. Here I will only say that 
I believe that systems immunology opens up a qualitatively different avenue for studying the 
immune system which was not previously available. I am not claiming systems immunology 
is the only correct way to study the immune system or even the best way, but simply because 
it is new it is worthy of exploration. As the scenario that we might never be able to fully 
comprehend the workings of the immune system seems like a possible scenario, I believe 
systems immunology to offer a reasonable alternative.  
  51 
Even if it would turn out that the immune system is too complex for us to understand, 
systems immunology might still be able to offer the prospect of mathematical description 
and, possibly, enable prediction. It is important to remember that successfully treating 
immune-mediated disease or developing immune-mediated therapies doesn’t really require an 
intuitive understanding of the system as much as a mathematical one. Perhaps methods from 
the fields of machine learning and artificial intelligence can be used not to increase our 
understanding, but simply to aid us in interpreting complex data on the immune system and 
advise us on how to manipulate it in order to achieve a particular result, such as curing a 
disease or eradicating an infection.  
In 2016, the computer program AlphaGo beat world champion Lee Sedol in 5 rounds of the 
board game go by 4-1. Since then, the algorithm has been extended to a more general 
framework, AlphaZero, which is capable of mastering go, chess, and the Japanese chess 
variant shogi160. AlphaZero employs a self-learning algorithm, meaning it only requires the 
rules for a particular game, unlike most previous software which are trained using records of 
games played by humans. During games of go, it happens that AlphaZero makes a move that 
looks like a mistake at the time, even to experts, but that turns out to be brilliant in the post-
game analysis. If artificial intelligence is ever to be used in the study of the human immune 
system, the capability to transcend human understanding in this way must surely count as an 
important advantage. It is still way too early to tell whether this is even a realistic scenario, as 
the immune system is a lot more complicated than the games of go and chess. Regardless, if it 
turns out to be the case, systems immunology stands out as the most promising research 
framework in which to develop such technologies. 
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